Search Results 711-720 of 17526 for Metformin

  1. A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas - Mayo Clinic

    The purpose of this study is to determine the efficacy of pembrolizumab in patients with advanced sarcomas. Participation eligibility. Participant eligibility ...

  2. Mandy J. Strong - Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  3. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension - Mayo Clinic

    The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.

  4. Study To Determine Risk Factors For Post-operative Infection In Inflammatory Bowel Disease - Mayo Clinic

    Understanding of how best to treat inflammatory bowel disease (IBD) has evolved over the last ten years. Evidence now suggests that the most effective ...

  5. Desmopressin (sublingual route) - Side effects & dosage - Mayo Clinic

    Your doctor may tell you to collect and measure your urine and the times that you urinate for 24 hours to determine if you have nocturnal polyuria. Desmopressin ...

  6. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001) - Mayo Clinic

    About this study. This study aims to create a registry for primary melanoma gene-signature to predict sentinel node (SN) status and determine its prognostic ...

  7. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  8. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease - Mayo Clinic

    About this study. This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data ...

  9. Z-Endoxifen Hydrochloride in Treating Patients with Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer - Mayo Clinic

    Hormone therapy using Z-endoxifen hydrochloride may fight breast cancer by blocking the use of estrogen by tumor cells. Participation eligibility. Participant ...

  10. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...